Dr. Saroja M K

• Spearheaded the engagement of high-value corporate clients, delivering comprehensive end-to-end solutions with a keen focus on commercial viability.
• Adoption and integration of cutting-edge technologies such as SomaLogic, 10x Genomics, and BioSkryb into Genotypic Technology's innovative business lines.
• Provided expert training and support to both internal and external stakeholders on advanced technology platforms.
• Extensive support from inception to closure to all cross functional teams.
• Conducted numerous scientific and technical presentations and workshops at prestigious academic and research institutions to promote genomics and proteomics services.
• Presented findings from data analytics to senior Management facilitating key decisions on company strategy.

• Excelled in a techno-commercial capacity, evaluating project feasibility, designing studies, and proposing tailored genomics solutions.
• Established strong relationships with clients and stakeholders, ensuring long-term partnerships and repeat business.
• Led cross-functional teams to achieve project milestones and deliver high-quality results.
• Improved team performance by developing and providing technical content, comprehensive training and fostering a collaborative work environment.
• Collaborated with internal and external stake holders to enhance service offerings, ensuring effective and practical solutions.
• Achieved significant cost savings by innovating functional approaches to targeted sequencing and methylation studies.
• Led the ISO compliance and ICC ( For policy on Sexual harassment) committees at Genotypic Technology, ensuring adherence to the highest standards.

• Managed the NGS laboratory as a Group Leader, overseeing diverse service projects with a team of scientific analysts.
• Contributed to Next generation sequencing laboratory at Genotypic to streamline theprocesses for increased effeciency on multiple technology platforms like Illumina, Ion Proton and ABISOLiD.
• Pioneered protocol optimization for non-standard applications and played a critical role in optimization of long-read Oxford Nanopore technology during early days of introduction to Indian market.
• Designed custom NGS panels and analysis strategies for targeted sequencing for clinical/research samples Develop technical content and provide access to internal/external stakeholders
• Achieved cost-effectiveness by devising functional solutions to targeted sequencing, Methylation studies etc
• Optimized resource allocation by forecasting staffing needs based on project timelines and objectives.
• Developed strong relationships with clients through consistent communication and collaboration.

• Lead a team of three scientists in execution of projects on Agilent microarray platform for RNA and DNA based experiments.
• Fostered collaboration with array design and analysis teams to elevate data quality and integrity.
• Efficiently managed both human resources and reagents. Streamlined processes for increased efficiency and improved project outcomes.
• Interactions with array design and analysis teams to improve data quality
• ISO compliance related documentation in lab.
• Mentored junior team members, contributing to their professional growth and development.

• Played a lead role in the project Recombinant approach for the production of DHA/ PUFAs in yeast: Funded by CSIR under NMITLI programme
• Cloning and expression of novel DHA biosynthetic pathway genes in yeast
• CDNA and BAC library constructions and screening for genes of interest
• Performed cloning, codon optimization, transformation and proof of function studies in yeast
• Primer designing, codon optimization and software tools sequence analysis
• Compilation of progress reports to submit to NMITLI steering committee meetings.

Biosmilars development
Cloned and expressed biosimilar in E.Coli , yeast (Both S.Cerevisiae and Pichia) and mammalian systems.

Marker aided selection for plant breeding and purity testing
Genotyping through SSR markers for rice purity testing.

RAPD and AFLP Fingerprinting for seed lot testing

cDNA AFLP fingerprinting to study differentially expressed genes in Normal, Tumour and treated samples.